A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy

We report a case of initial lung adenocarcinoma in which transformation to small cell lung carcinoma (SCLC) was observed after acquired resistance to the 3(rd) generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) osimertinib and alternating treatment between chemotherapy...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ann Transl Med
Hoofdauteurs: Hirakawa, Haruki, Komiya, Kazutoshi, Nakashima, Chiho, Ogusu, Shinske, Nakamura, Tomomi, Tanaka, Masahide, Takahashi, Koichiro, Egashira, Yoshiaki, Kai, Keita, Kimura, Shinya, Sueoka-Aragane, Naoko
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2018
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312808/
https://ncbi.nlm.nih.gov/pubmed/30603652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.11.25
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items